|
|
Positive stool culture could predict the clinical outcomes of haploidentical hematopoietic stem cell transplantation |
Lijuan Hu1, Qi Wang4, Xiaohui Zhang1, Lanping Xu1, Yu Wang1, Chenhua Yan1, Huan Chen1, Yuhong Chen1, Kaiyan Liu1, Hui Wang4, Xiaojun Huang1,2,3, Xiaodong Mo1() |
1. Peking University People’s Hospital, Peking University Institute of Hematology, Beijing 100044, China 2. Peking-Tsinghua Center for Life Sciences, Beijing 100044, China 3. Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China 4. Peking University People’s Hospital, Department of Clinical Laboratory, Beijing 100044, China |
|
|
Abstract We aimed to identify the effect of positive stool cultures (PSCs) on the clinical outcomes of patients undergoing haploidentical hematopoietic stem cell transplantation (haplo-HSCT) (n = 332). PSCs were observed in 61 patients (PSC group, 18.4%). Enterobacteriaceae in stool specimens was associated with a higher risk of bloodstream infection, and Candida in stool specimens was related to a higher risk of platelet engraftment failure. The cumulative incidence of infection-related mortality 1 year after haplo-HSCT in the PSC group was higher than that of the patients who showed persistently negative stool cultures (NSC group; 19.2% vs. 8.9%, P = 0.017). The probabilities of overall survival (71.4% vs. 83.8%, P = 0.031) and disease-free survival (69.6% vs. 81.0%, P = 0.048) 1 year after haplo-HSCT for the PSC group were significantly lower than those for the NSC group, particularly for patients who had Candida in their stool specimens. In multivariate analysis, Candida in stool specimens significantly increased the risk of mortality and was associated with poorer survival. Our results showed that PSC influenced the clinical outcomes after haplo-HSCT, particularly those who had Candida in their stool specimens.
|
Keywords
haploidentical
hematopoietic stem cell transplantation
stool culture
Candida
|
Corresponding Author(s):
Xiaodong Mo
|
Just Accepted Date: 01 March 2019
Online First Date: 08 April 2019
Issue Date: 02 August 2019
|
|
1 |
M Lv, XJ Huang. Allogeneic hematopoietic stem cell transplantation in China: where we are and where to go. J Hematol Oncol 2012; 5(1): 10
https://doi.org/10.1186/1756-8722-5-10
pmid: 22424172
|
2 |
Y Wang, QF Liu, LP Xu, KY Liu, XH Zhang, X Ma, ZP Fan, DP Wu, XJ Huang. Haploidentical vs. identical-sibling transplant for AML in remission: a multicenter, prospective study. Blood 2015; 125(25): 3956–3962
https://doi.org/10.1182/blood-2015-02-627786
pmid: 25940714
|
3 |
Y Wang, QF Liu, LP Xu, KY Liu, XH Zhang, X Ma, MQ Wu, DP Wu, XJ Huang. Haploidentical versus matched-sibling transplant in adults with Philadelphia-negative high-risk acute lymphoblastic leukemia: a biologically phase III randomized study. Clin Cancer Res 2016; 22(14): 3467–3476
https://doi.org/10.1158/1078-0432.CCR-15-2335
pmid: 26927664
|
4 |
Y Wang, HX Wang, YR Lai, ZM Sun, DP Wu, M Jiang, DH Liu, KL Xu, QF Liu, L Liu, JB Wang, F Gao, J Ou-Yang, SJ Gao, LP Xu, XJ Huang. Haploidentical transplant for myelodysplastic syndrome: registry-based comparison with identical sibling transplant. Leukemia 2016; 30(10): 2055–2063
https://doi.org/10.1038/leu.2016.110
pmid: 27133816
|
5 |
LP Xu, DP Wu, MZ Han, H Huang, QF Liu, DH Liu, ZM Sun, LH Xia, J Chen, HX Wang, C Wang, CF Li, YR Lai, JM Wang, DB Zhou, H Chen, YP Song, T Liu, KY Liu, XJ Huang. A review of hematopoietic cell transplantation in China: data and trends during 2008–2016. Bone Marrow Transplant 2017; 52(11): 1512–1518
https://doi.org/10.1038/bmt.2017.59
pmid: 28436973
|
6 |
L Xu, H Chen, J Chen, M Han, H Huang, Y Lai, D Liu, Q Liu, T Liu, M Jiang, H Ren, Y Song, Z Sun, J Wang, D Wu, D Zhou, P Zou, K Liu, X Huang. The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China-recommendations from the Chinese Society of Hematology. J Hematol Oncol 2018; 11(1): 33
https://doi.org/10.1186/s13045-018-0564-x
pmid: 29495966
|
7 |
XJ Huang, YJ Chang. Unmanipulated HLA-mismatched/haploidentical blood and marrow hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2011; 17(2): 197–204
https://doi.org/10.1016/j.bbmt.2010.03.006
pmid: 20302961
|
8 |
EJ Fuchs. HLA-haploidentical blood or marrow transplantation with high-dose, post-transplantation cyclophosphamide. Bone Marrow Transplant 2015; 50(S2 Suppl 2): S31–S36
https://doi.org/10.1038/bmt.2015.92
pmid: 26039204
|
9 |
JU Scher, A Sczesnak, RS Longman, N Segata, C Ubeda, C Bielski, T Rostron, V Cerundolo, EG Pamer, SB Abramson, C Huttenhower, DR Littman. Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. eLife 2013; 2: e01202
https://doi.org/10.7554/eLife.01202
pmid: 24192039
|
10 |
MI Smith, T Yatsunenko, MJ Manary, I Trehan, R Mkakosya, J Cheng, AL Kau, SS Rich, P Concannon, JC Mychaleckyj, J Liu, E Houpt, JV Li, E Holmes, J Nicholson, D Knights, LK Ursell, R Knight, JI Gordon. Gut microbiomes of Malawian twin pairs discordant for kwashiorkor. Science 2013; 339(6119): 548–554
https://doi.org/10.1126/science.1229000
pmid: 23363771
|
11 |
PJ Turnbaugh, M Hamady, T Yatsunenko, BL Cantarel, A Duncan, RE Ley, ML Sogin, WJ Jones, BA Roe, JP Affourtit, M Egholm, B Henrissat, AC Heath, R Knight, JI Gordon. A core gut microbiome in obese and lean twins. Nature 2009; 457(7228): 480–484
https://doi.org/10.1038/nature07540
pmid: 19043404
|
12 |
J Qin, Y Li, Z Cai, S Li, J Zhu, F Zhang, S Liang, W Zhang, Y Guan, D Shen, Y Peng, D Zhang, Z Jie, W Wu, Y Qin, W Xue, J Li, L Han, D Lu, P Wu, Y Dai, X Sun, Z Li, A Tang, S Zhong, X Li, W Chen, R Xu, M Wang, Q Feng, M Gong, J Yu, Y Zhang, M Zhang, T Hansen, G Sanchez, J Raes, G Falony, S Okuda, M Almeida, E LeChatelier, P Renault, N Pons, JM Batto, Z Zhang, H Chen, R Yang, W Zheng, S Li, H Yang, J Wang, SD Ehrlich, R Nielsen, O Pedersen, K Kristiansen, J Wang. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 2012; 490(7418): 55–60
https://doi.org/10.1038/nature11450
pmid: 23023125
|
13 |
MD Docampo, JJ Auletta, RR Jenq. Emerging influence of the intestinal microbiota during allogeneic hematopoietic cell transplantation: control the gut and the body will follow. Biol Blood Marrow Transplant 2015; 21(8): 1360–1366
https://doi.org/10.1016/j.bbmt.2015.02.016
pmid: 25708215
|
14 |
Y Shono, MRM van den Brink. Gut microbiota injury in allogeneic haematopoietic stem cell transplantation. Nat Rev Cancer 2018; 18(5): 283–295
https://doi.org/10.1038/nrc.2018.10
pmid: 29449660
|
15 |
XJ Huang, DH Liu, KY Liu, LP Xu, H Chen, W Han, YH Chen, XH Zhang, DP Lu. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation. Biol Blood Marrow Transplant 2009; 15(2): 257–265
https://doi.org/10.1016/j.bbmt.2008.11.025
pmid: 19167686
|
16 |
Y Wang, DH Liu, KY Liu, LP Xu, XH Zhang, W Han, H Chen, YH Chen, FR Wang, JZ Wang, YQ Sun, XJ Huang. Long-term follow-up of haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of leukemia: nine years of experience at a single center. Cancer 2013; 119(5): 978–985
https://doi.org/10.1002/cncr.27761
pmid: 23097265
|
17 |
XJ Huang, DH Liu, KY Liu, LP Xu, H Chen, W Han, YH Chen, JZ Wang, ZY Gao, YC Zhang, Q Jiang, HX Shi, DP Lu. Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies. Bone Marrow Transplant 2006; 38(4): 291–297
https://doi.org/10.1038/sj.bmt.1705445
pmid: 16883312
|
18 |
XD Mo, XH Zhang, LP Xu, Y Wang, CH Yan, H Chen, YH Chen, W Han, FR Wang, JZ Wang, KY Liu, XJ Huang. Late-onset severe pneumonia after allogeneic hematopoietic stem cell transplantation: prognostic factors and treatments. Transpl Infect Dis 2016; 18(4): 492–503
https://doi.org/10.1111/tid.12553
pmid: 27218435
|
19 |
P Armand, HT Kim, BR Logan, Z Wang, EP Alyea, ME Kalaycio, RT Maziarz, JH Antin, RJ Soiffer, DJ Weisdorf, JD Rizzo, MM Horowitz, W Saber. Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation. Blood 2014; 123(23): 3664–3671
https://doi.org/10.1182/blood-2014-01-552984
pmid: 24744269
|
20 |
D Przepiorka, D Weisdorf, P Martin, HG Klingemann, P Beatty, J Hows, ED Thomas. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995; 15(6): 825–828
pmid: 7581076
|
21 |
TA Gooley, W Leisenring, J Crowley, BE Storer. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 1999; 18(6): 695–706
https://doi.org/10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O
pmid: 10204198
|
22 |
C Huisman, HM van der Straaten, MR Canninga-van Dijk, R Fijnheer, LF Verdonck. Pulmonary complications after T-cell-depleted allogeneic stem cell transplantation: low incidence and strong association with acute graft-versus-host disease. Bone Marrow Transplant 2006; 38(8): 561–566
https://doi.org/10.1038/sj.bmt.1705484
pmid: 16953211
|
23 |
CS Chen, M Boeckh, K Seidel, JG Clark, E Kansu, DK Madtes, JL Wagner, RP Witherspoon, C Anasetti, FR Appelbaum, WI Bensinger, HJ Deeg, PJ Martin, JE Sanders, R Storb, J Storek, J Wade, M Siadak, ME Flowers, KM Sullivan. Incidence, risk factors, and mortality from pneumonia developing late after hematopoietic stem cell transplantation. Bone Marrow Transplant 2003; 32(5): 515–522
https://doi.org/10.1038/sj.bmt.1704162
pmid: 12942099
|
24 |
MJ Krowka, EC Rosenow 3rd, HC Hoagland. Pulmonary complications of bone marrow transplantation. Chest 1985; 87(2): 237–246
https://doi.org/10.1378/chest.87.2.237
pmid: 2981658
|
25 |
P Chevallier, I Hebia-Fellah, L Planche, T Guillaume, C Bressolette-Bodin, M Coste-Burel, F Rialland, M Mohty, BM Imbert-Marcille. Human herpes virus 6 infection is a hallmark of cord blood transplant in adults and may participate to delayed engraftment: a comparison with matched unrelated donors as stem cell source. Bone Marrow Transplant 2010; 45(7): 1204–1211
https://doi.org/10.1038/bmt.2009.326
pmid: 19935727
|
26 |
XD Mo, X Yan, W Hu, XH Zhang, LP Xu, Y Wang, XD Xu, LN Wang, XX He, CH Yan, H Chen, YH Chen, KY Liu, XJ Huang. Perianal infections in the phase before engraftment after allogeneic hematopoietic stem cell transplantations: a study of the incidence, risk factors, and clinical outcomes. Acta Haematol 2018; 139(1): 19–27
https://doi.org/10.1159/000481723
pmid: 29320771
|
27 |
X Zhao, X Zhao, M Huo, Q Fan, X Pei, Y Wang, X Zhang, L Xu, X Huang, K Liu, Y Chang. Donor-specific anti-human leukocyte antigen antibodies predict prolonged isolated thrombocytopenia and inferior outcomes of haploidentical hematopoietic stem cell transplantation. J Immunol Res 2017; 2017: 1043836
https://doi.org/10.1155/2017/1043836
pmid: 28484721
|
28 |
I Zollner-Schwetz, HW Auner, A Paulitsch, W Buzina, PB Staber, P Ofner-Kopeinig, EC Reisinger, H Olschewski, R Krause. Oral and intestinal Candida colonization in patients undergoing hematopoietic stem-cell transplantation. J Infect Dis 2008; 198(1): 150–153
https://doi.org/10.1086/588827
pmid: 18491972
|
29 |
M Nucci, E Anaissie. Revisiting the source of candidemia: skin or gut? Clin Infect Dis 2001; 33(12): 1959–1967
https://doi.org/10.1086/323759
pmid: 11702290
|
30 |
J Bilinski, K Robak, Z Peric, H Marchel, E Karakulska-Prystupiuk, K Halaburda, P Rusicka, E Swoboda-Kopec, M Wroblewska, W Wiktor-Jedrzejczak, GW Basak. Impact of gut colonization by antibiotic-resistant bacteria on the outcomes of allogeneic hematopoietic stem cell transplantation: a retrospective, single-center study. Biol Blood Marrow Transplant 2016; 22(6): 1087–1093
https://doi.org/10.1016/j.bbmt.2016.02.009
pmid: 26900084
|
31 |
A Sadowska-Klasa, A Piekarska, W Prejzner, M Bieniaszewska, A Hellmann. Colonization with multidrug-resistant bacteria increases the risk of complications and a fatal outcome after allogeneic hematopoietic cell transplantation. Ann Hematol 2018; 97(3): 509–517
https://doi.org/10.1007/s00277-017-3205-5
pmid: 29255911
|
32 |
Y Taur, JB Xavier, L Lipuma, C Ubeda, J Goldberg, A Gobourne, YJ Lee, KA Dubin, ND Socci, A Viale, MA Perales, RR Jenq, MR van den Brink, EG Pamer. Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 2012; 55(7): 905–914
https://doi.org/10.1093/cid/cis580
pmid: 22718773
|
33 |
JM Vossen, PJ Heidt, H van den Berg, EJ Gerritsen, J Hermans, LJ Dooren. Prevention of infection and graft-versus-host disease by suppression of intestinal microflora in children treated with allogeneic bone marrow transplantation. Eur J Clin Microbiol Infect Dis 1990; 9(1): 14–23
https://doi.org/10.1007/BF01969527
pmid: 2105890
|
34 |
DD Poutsiaka, LL Price, A Ucuzian, GW Chan, KB Miller, DR Snydman. Blood stream infection after hematopoietic stem cell transplantation is associated with increased mortality. Bone Marrow Transplant 2007; 40(1): 63–70
https://doi.org/10.1038/sj.bmt.1705690
pmid: 17468772
|
35 |
O Blennow, P Ljungman, E Sparrelid, J Mattsson, M Remberger. Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations. Transpl Infect Dis 2014; 16(1): 106–114
https://doi.org/10.1111/tid.12175
pmid: 24372809
|
36 |
CH Yan, T Xu, XY Zheng, J Sun, XL Duan, JL Gu, CL Zhao, J Zhu, YH Wu, DP Wu, JD Hu, H Huang, M Jiang, J Li, M Hou, C Wang, ZH Shao, T Liu, Y Hu, XJ Huang. Epidemiology of febrile neutropenia in patients with hematological disease—a prospective multicentre survey in China. Chin J Hematol (Zhonghua Xue Ye Xue Za Zhi) 2016; 37(3): 177–182 (in Chinese)
pmid: 27033752
|
37 |
DW van Bekkum, J Roodenburg, PJ Heidt, D van der Waaij. Mitigation of secondary disease of allogeneic mouse radiation chimeras by modification of the intestinal microflora. J Natl Cancer Inst 1974; 52(2): 401–404
https://doi.org/10.1093/jnci/52.2.401
pmid: 4150164
|
38 |
JM Jones, R Wilson, PM Bealmear. Mortality and gross pathology of secondary disease in germfree mouse radiation chimeras. Radiat Res 1971; 45(3): 577–588
https://doi.org/10.2307/3573066
pmid: 4396814
|
39 |
DW Beelen, A Elmaagacli, KD Müller, H Hirche, UW Schaefer. Influence of intestinal bacterial decontamination using metronidazole and ciprofloxacin or ciprofloxacin alone on the development of acute graft-versus-host disease after marrow transplantation in patients with hematologic malignancies: final results and long-term follow-up of an open-label prospective randomized trial. Blood 1999; 93(10): 3267–3275
pmid: 10233878
|
40 |
FB Petersen, CD Buckner, RA Clift, N Nelson, GW Counts, JD Meyers, ED Thomas. Infectious complications in patients undergoing marrow transplantation: a prospective randomized study of the additional effect of decontamination and laminar air flow isolation among patients receiving prophylactic systemic antibiotics. Scand J Infect Dis 1987; 19(5): 559–567
https://doi.org/10.3109/00365548709032423
pmid: 3321413
|
41 |
JR Passweg, PA Rowlings, KA Atkinson, AJ Barrett, RP Gale, A Gratwohl, N Jacobsen, JP Klein, P Ljungman, JA Russell, UW Schaefer, KA Sobocinski, JM Vossen, MJ Zhang, MM Horowitz. Influence of protective isolation on outcome of allogeneic bone marrow transplantation for leukemia. Bone Marrow Transplant 1998; 21(12): 1231–1238
https://doi.org/10.1038/sj.bmt.1701238
pmid: 9674857
|
42 |
D Weber, RR Jenq, JU Peled, Y Taur, A Hiergeist, J Koestler, K Dettmer, M Weber, D Wolff, J Hahn, EG Pamer, W Herr, A Gessner, PJ Oefner, MRM van den Brink, E Holler. Microbiota disruption induced by early use of broad-spectrum antibiotics is an independent risk factor of outcome after allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2017; 23(5): 845–852
https://doi.org/10.1016/j.bbmt.2017.02.006
pmid: 28232086
|
43 |
Y Shono, MD Docampo, JU Peled, SM Perobelli, E Velardi, JJ Tsai, AE Slingerland, OM Smith, LF Young, J Gupta, SR Lieberman, HV Jay, KF Ahr, KA Porosnicu Rodriguez, K Xu, M Calarfiore, H Poeck, S Caballero, SM Devlin, F Rapaport, JA Dudakov, AM Hanash, B Gyurkocza, GF Murphy, C Gomes, C Liu, EL Moss, SB Falconer, AS Bhatt, Y Taur, EG Pamer, MRM van den Brink, RR Jenq. Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice. Sci Transl Med 2016; 8(339): 339ra71
https://doi.org/10.1126/scitranslmed.aaf2311
pmid: 27194729
|
44 |
A Staffas, M Burgos da Silva, MR van den Brink. The intestinal microbiota in allogeneic hematopoietic cell transplant and graft-versus-host disease. Blood 2017; 129(8): 927–933
https://doi.org/10.1182/blood-2016-09-691394
pmid: 27940475
|
45 |
RM Shallis, CM Terry, SH Lim. Changes in intestinal microbiota and their effects on allogeneic stem cell transplantation. Am J Hematol 2018; 93(1): 122–128
https://doi.org/10.1002/ajh.24896
pmid: 28842931
|
46 |
C Ubeda, Y Taur, RR Jenq, MJ Equinda, T Son, M Samstein, A Viale, ND Socci, MR van den Brink, M Kamboj, EG Pamer. Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. J Clin Invest 2010; 120(12): 4332–4341
https://doi.org/10.1172/JCI43918
pmid: 21099116
|
47 |
Y Taur, RR Jenq, MA Perales, ER Littmann, S Morjaria, L Ling, D No, A Gobourne, A Viale, PB Dahi, DM Ponce, JN Barker, S Giralt, M van den Brink, EG Pamer. The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation. Blood 2014; 124(7): 1174–1182
https://doi.org/10.1182/blood-2014-02-554725
pmid: 24939656
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|